Introduction {#s1}
============

Stress, in varying degrees and of varying durations, impacts every single human and has a major influence on their health ([@B1]). Healthy individuals typically can manage short, acute episodes of routine stress without health consequences. However, if stress becomes persistent, the long-term effects can significantly impair mental and physiological well-being ([@B2]). When recognized, people can often address and ideally eliminate specific acute stressors ([@B3]). Chronic stress, however, is often insidious and develops slowly, making it difficult for an individual experiencing it to recognize it ([@B4]). In addition, the marked variability in stress responses among individuals can make it difficult to be clearly recognized by others, including family and even mental health professionals ([@B5]). Therefore, there is a critical need for objective, reproducible measures of an individual\'s ability to recover from stress.

The autonomic nervous system (ANS) plays an important role in the body\'s response to stress. Composed of the parasympathetic and sympathetic nervous systems (PNS and SNS) ([@B1]), the response to stress is driven primarily by the SNS and the hypothalamic--pituitary--adrenocortical axis ([@B1], [@B6]). On the other hand, the PNS is important in alleviating the stress response ([@B7]). While at present there is no universally accepted standard for objective stress measurement ([@B8]), fluctuations in the length of heartbeat intervals, commonly referred to as heart rate variability (HRV) ([@B6], [@B9], [@B10]), which is under the control of the ANS, has been found in a number of studies to be a potentially viable objective biomarker of the stress response ([@B6]). HRV also has the advantage of being non-invasively and potentially continuously measured, typically using an electrocardiogram.

Historically, one of the challenges to demonstrating the effectiveness of wellness interventions has been a focus on a population-wide effect that is based on a single "snapshot" recording taken before and after the intervention, typically in an artificial setting outside of routine daily activities. This approach, however, is often hampered by the wide interindividual variability in physiological parameters at baseline and in responsiveness to the intervention, as well as intraindividual variability that is common throughout the day. The noise created by these multiple sources of variation can easily overwhelm any metric of change that is population based and prevents identifying potentially important changes in an individual. However, with the recent growth in consumer-grade devices and wearables ([@B11], [@B12]), new and innovative ways of collecting real-world ([@B13]) multi physiological data for prolonged periods of time have become feasible ([@B14], [@B15]). This rich data allow for a detailed and personalized analysis of normal physiological changes and how they relate to each other, over time, and in the daily lives of people. Such a multivariate longitudinal measure of an individual\'s physiology can enable assessment of short- and long-term changes in the functioning of the autonomous nervous system ([@B16], [@B17]) especially relative to one\'s own baseline. In particular, features related to HRV, generated using biosignals obtained from continual monitoring of heart, have been linked with ANS-related neurocardiac functioning such as stress, autonomic balance, blood pressure (BP), and vascular tone including being impacted by external environmental and psychological variations over time ([@B18], [@B19]). To quantify such complex and dynamic non-linear associations between ANS functioning and HRV, it is recommended to use both the time and frequency domain features of HRV ([@B10], [@B20]). Briefly, time-domain HRV features ([@B21], [@B22]) quantify the variation in the interbeat interval (IBI) between successive heartbeats with standard deviation of the IBI of normal sinus beats \[standard deviation of interbeat intervals (SDNN)\] considered the gold standard for clinical cardiac risk evaluation ([@B23]). The frequency- and amplitude-based HRV features are derived based on power spectral analysis ([@B24]) to derive energy within a prespecified four frequency bands ([@B23]). Of these, the low-frequency (LF) (0.04--0.15 Hz, between 7 and 25 s) band has been linked to vagal and sympathetic activity, whereas the high-frequency (0.15--0.4 Hz, between 2.5 and 7 s) has been linked to parasympathetic activity of the ANS ([@B20]). Salivary cortisol is another frequently used biomarker of stress as a measure of hypothalamus--pituitary--adrenal axis (HPAA) activity. Obtaining repeated saliva samples during the course of a day is an established method of determining the diurnal variation of cortisol, including for intervention studies ([@B25], [@B26]).

In the current study, utilizing a novel sensor patch that could monitor multiple physiological parameters, including ECG, continuously for up to 7 days, we investigated whether it was feasible to detect changes in HRV relative to a participant\'s baseline, in response to two different week-long wellness programs, one a structured wellness program and the other an unstructured wellness vacation at the same resort location ([@B27]). We further explored if changes in HRV sustained over a period of time by remotely monitoring participants 1 month after the interventions. Additionally, any significant differences in salivary cortisol levels across home, wellness center visit, and across the two cohorts were also assessed for their relationship to HRV.

Methods {#s2}
=======

Study Participants and Design
-----------------------------

Participants were recruited via email announcements from the UC San Diego faculty and staff and Chopra Center for Well-Being mailing lists. The announcements described the Self-Directed Biological Transformation Initiative (SBTI), a research study examining the effects of a structured wellness program based on Ayurvedic principles called the Perfect Health Program (PH) or an unstructured vacation retreat (RELAX) ([@B28]). The majority of enrolled participants were from the greater San Diego and Los Angeles areas. Flyers stated that the week-long ([@B28]) study would be conducted at the La Costa Resort in Carlsbad, CA and that participants would either participate in the PH program or take a regular vacation at the same resort. All study participants stayed onsite at the resort for 1 week ([Figure 1](#F1){ref-type="fig"}). The study was approved by the UC San Diego Institutional Review Board (\#171715) and was registered on [ClinicalTrials.gov](https://clinicaltrials.gov/) with Identifier: NCT02241226.

![Overall schematic flow of the study showing participant recruitment, screening, consent, and wearable sensor-based tracking of physiological characteristics across the three sessions. The week prior to starting the program (session 1), the last 2 days of the respective intervention program (session 2), and at home \~1 month after completion of the intervention programs (session 3).](fcvm-07-00120-g0001){#F1}

Eligible participants were healthy English-speaking women and men aged 30--80 years with no current major medical or mental illnesses. Exclusion criteria included being a smoker, pregnancy, estrogen or hormone replacement therapy, a body mass index (BMI) ≥35 kg/m^2^, and current use of non-prescription drugs. Individuals were not excluded if they took prescription drugs. Participants were willing to refrain from drinking more than one alcoholic beverage per day during the weeklong stay at the resort. Finally, individuals who have previously participated in the PH program or other Chopra Center programs or a yoga or meditation retreat of any kind within the past 12 months were also excluded from study participation.

A total of 261 individuals were screened for eligibility, learned details of study involvement, and were asked to consider their commitment and availability before they were enrolled in the study. It was emphasized that this included a commitment to stay in the study even if they were not randomized into their preferred group. A total of 112 individuals consented to enroll in the study and were randomly assigned in a 1:2 ratio to either the PH group or the RELAX group. Within the enrolled cohort, a group of 23 individuals (20.5%) who were previously planning to take the PH program were assigned to the PH program in a non-randomized fashion. There were no expenses for participation in the study. Participants were not compensated financially or with any type of non-financial incentives other than having their expenses covered while at the resort.

Study Interventions
-------------------

The intervention groups were not blinded, and site investigators and study personnel knew to which group participants were assigned. The two groups had no contact with each other during the study and did not know the details of the daily schedule of the other group. Upon arrival at the resort, participants were given a 1-h orientation meeting with the study team where they learned about the overall study schedule and procedures and the assessment schedules.

PH Program Intervention
-----------------------

PH is essentially an Ayurvedic immersion program of detoxification and rejuvenation that is based on core principles from the Ayurvedic system of medicine ([@B28]). The program was developed \~20 years ago, with \~800 individuals taking the course every year. The PH program addresses the physical, emotional, and spiritual well-being through daily practices and lectures. Components of the program included physical cleansing through ingestion of herbs, fiber, and oils, two Ayurvedic meals daily (breakfast and lunch), which provided a light plant-based diet, daily Ayurvedic massage treatments, and heating treatments through the use of dry sauna and/or steam sauna. The program includes lectures on Ayurvedic principles and lifestyle as well as lectures on meditation and yoga philosophy. The PH study group participated in twice-daily group meditation and daily yoga, practiced breathing exercises, as well as emotional expression through a process of journaling and emotional support. The daily yoga practice consisted of a standard set of 10 yoga postures. During the program, PH participants received a 1-h integrative medical consultation with a physician and a follow-up with an Ayurvedic health educator. The teachers of the PH Program delivered their standard program to the SBTI study participants.

RELAX Intervention
------------------

Participants randomized to the RELAX group were asked to do what they would normally do on a resort vacation with the additional following restrictions: they were asked not to engage in more exercise than they would in their normal lifestyle and to refrain from using La Costa Resort spa services. RELAX participants were also asked not to drink ginger tea or take gingko biloba during the 2 days prior to and during the study week.

Salivary Cortisol
-----------------

To assess diurnal variations in cortisol levels, saliva samples at four different periods were collected: at the participant\'s home the week prior to coming to the retreat, day 1 of the retreat, day 6 of the retreat, and at home 1 month following the retreat. Participants were provided an information sheet on how to properly self-collect, label, and store their saliva samples. Participants collected their saliva into salimetrics saliva collection tubes using the passive drool method at the following times: immediately upon awakening, 30 min post-awakening, noon, 4:30 [pm]{.smallcaps}, 8:00 [pm]{.smallcaps}, and bedtime. Upon collection, participants put their samples on ice or in a −20°C freezer. For samples collected at home, participants placed the samples on ice packs and sent them to the UC San Diego Clinical Research Biomarker Laboratory samples using overnight shipping, where they were placed in −80°C until assay ([@B29]). Saliva cortisol levels were determined by commercial ELISA (Salimetrics, Carlsbad, CA, USA). Intraassay coefficients of variation were \<5%; interassay coefficients of variation were \<8%.

Continual Physiological Monitoring
----------------------------------

An adhesive wearable patch (MultiSense™) developed by Rhythm Diagnostic Systems (RDS), which has multiple sensors embedded in a "Band-Aid"-like strip ([Figure 2](#F2){ref-type="fig"}), was used to continually monitor multiple physiological parameters of study participants. MultiSense™ wearable patch is a self-contained, reusable, rechargeable, battery-powered, flexible strip, measuring 4 × 1.2 in and weighs \<15 g. The MultiSense device collects and stores raw biosensor data from a single lead ECG, a three-axis accelerometer, a skin temperature sensor, and a Red and IR photoplethysmography (PPG) sensor. The device stores all physiological data in onboard memory and can be worn for up to 10 days with the data then downloaded via USB.

![Picture of the Rhythm Diagnostic Systems (RDS) patch and recommended placement on the body.](fcvm-07-00120-g0002){#F2}

All study participants were asked to wear the sensor patch on three occasions: the week prior to starting the program (session 1), the last 2 days of the program (session 2), and at home \~1 month after completion of the program (session 3). The wearable sensor was one of the many components of a much broader SBTI program ([@B28], [@B30]).

Feature Extraction
------------------

Vital signs and physiological features were derived from the raw sensor data using a proprietary library of signal processing and data analytics algorithms developed by PhysIQ ([@B31]) ([Figure 3](#F3){ref-type="fig"}). The offline feature extraction engine, using the raw sensor data \[ECG, a three-axis accelerometer, PPG (red & IR)\], generated 22 cardiopulmonary-related features. For the present analyses, we used a subset of eight heart rate and HRV-related features ([Table 1](#T1){ref-type="table"}) that are known to be a potential biomarker for stress ([@B6], [@B32]).

![Schematic overview of feature extraction translating the raw sensor data collected using the Rhythm Diagnostic Systems (RDS) MultiSense patch.](fcvm-07-00120-g0003){#F3}

###### 

Brief description of features generated by the feature extraction engine that were used for the present analysis.

  **Vital sign label**   **Feature domain**   **Units**      **Description**
  ---------------------- -------------------- -------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  HR                     Time                 bpm            1-min trimmed mean time averages of beat-to-beat HR
  SDNN                   Time                 Milliseconds   1-min trimmed mean time averages of the trimmed (remove upper and lower 5% of samples) standard deviation of interbeat intervals (SDNN) in 30-s windows calculated every 5 s
  ACT                    Frequency            g\'s           1-min trimmed mean time averages of gross activity level (essentially overall movement in all directions combined)
  ALF                    Frequency            s^2^           1-min trimmed mean time averages of power in the low-frequency band of heart rate variability (0.040--0.150 Hz)
  AHF                    Frequency            s^2^           1-min trimmed mean time averages of power in the high-frequency band of heart rate variability (0.150--0.400 Hz)
  PHF                    Frequency            s^2^           1-min trimmed mean time averages of normalized power in the low-frequency band of heart rate variability (0.040--0.150 Hz)
  PLF                    Frequency            s^2^           1-min trimmed mean time averages of normalized power in the high-frequency band of heart rate variability
  LF/HF                  Frequency            --             1-min trimmed mean time averages of the ratio of low frequency to high-frequency HRV power
  ECG goodness           Time                 \%             1-min trimmed mean time averages of ECG signal quality metric (100% is good, 0% is bad)

In addition, an ECG signal quality metric was calculated that is designed to identify snippets of ECG data that can result in inaccurate feature calculations \[due to loss of signal, low signal-to-noise ratio (SNR), and motion artifacts). The algorithm is based on a combination of analyzing the kurtosis of 15-s moving windows of ECG data and heuristics rules that identify non-varying samples as well as completely random samples within each window. A binary decision is rendered for each 15-s window identifying it as either "usable" or "non-usable" in the context of the feature extraction engine. A decision is made every 5 s by sliding the window of ECG data by 10 s. A corresponding proportion is generated for each minute based on the 5-s positive decisions made during each window of data. This proportion is the ECG signal quality metric. A default threshold of 0.9 (90%) is used as a basis for feature calculation quality filtering. A filtered sample is replaced with a NaN (not-a-number) value, indicating that ECG data existed during the corresponding minute, but the calculated feature is very likely unreliable.

Statistical Analysis
--------------------

The evaluation of inter- and intraindividual changes in HRV overtime was a secondary and exploratory goal of the SBTI trial, and therefore, the randomization of participants into RELAX and PH interventions was not optimally powered to assess the difference between the interventions.

Prior to analysis, the data in the upper and lower 1% quantile of HR and HRV features were filtered out to exclude potential outliers in the data due to technical noise at the cohort level. Additionally, all data points identified as likely to be indicative of poor accuracy due to biosignal noise, and the presence of motion artifacts was removed from the downstream analysis. Those samples included any with a corresponding ECG signal quality metric that was \<90%. Finally, only those participants who contributed at least 24 h worth of continual sensing data were considered for the cohort-level analysis. Differences in demographics variables across the RELAX and PH groups were assessed using a chi-square test.

Generalized estimating equations (GEEs) ([@B33]) were used to estimate the population-level average effect of heart rate variability between (a) PH and RELAX cohorts, (b) three sessions (session 1: at home before the interventions; session 2: at the resort; session 3: at home 1 month after the respective intervention), and (c) diurnal variations of HRV. Briefly, a GEE is a semiparametric method to estimate population-averaged effects by accounting for time-invariant, unobservable differences within individuals using robust and unbiased standard errors. The GEE model accounted for covariates such as age, BMI, gender, and physical activity (estimated by the triaxial acceleration sensor onboard the MultiSense™ wearable patch; see [Table 1](#T1){ref-type="table"}). A tri-level interaction between the three covariates, cohort (RELAX and PH), three sessions, and diurnal variations, were used in the model to estimate the population level significance of these interactions on HRV. We also tried to account for the subject level heterogeneity using a linear mixed-effects (LME) modeling approach ([@B34], [@B35]). Several LME models were fit using the lmer ([@B36]) package with combinations of fixed and random effects; however, due to missing sensor data across the sessions for some subjects, most LME models did not converge and therefore were dropped from further analysis.

To further investigate the high interperson heterogeneity in HRV, a personalized "*N*-of-1" analysis approach was used to assess the significance of a visit to the resort (session 2) on HRV regardless of the intervention group that an individual was assigned. Newey--West robust regression ([@B37]) method was used to account for the serial correlation structure in the data. Briefly, this approach allows conducting robust regression modeling using a non-parametric kernel-based heteroskedasticity and autocorrelation consistent (HAC) estimator of the covariance matrix that is able to account for both heteroscedasticity and autocorrelation of unknown form. We further adopted the Newey--West HAC estimator, using Bartlett kernel, and the automatic bandwidth selection procedure ([@B38]), and implemented in the sandwich R package ([@B39]). Time-of-the-day and average acceleration were included as covariates to account for individual diurnal variations. All analysis was done using the R statistical programming language ([@B40]).

Results {#s3}
=======

Data Summary
------------

A total of 261 individuals were screened for the study of which 112 individuals (69 PH, 44 RELAX) were enrolled, contributing 11,355 h worth of continual sensor-based monitoring data using the RDS MultiSense™ patch ([Figure 4](#F4){ref-type="fig"}). Of these, 87 participants (57 PH, 30 RELAX) wore the patch and contributed at least 24 h of physiological monitoring data and were included in the population-level analysis. A smaller subset of the sample (*N* = 43) contributed at least 24 h of data for two out of the three sessions, and finally, 22 (16 PH, 6 RELAX) participants contributed at least 24 h of data for all three sessions ([Supplementary Figure 1](#SM1){ref-type="supplementary-material"}). Overall, no significant difference in baseline demographic characteristics was seen between the participants in PH and RELAX cohorts including the subset of participants that were non-randomly assigned to PH intervention ([Supplementary Table 1](#SM1){ref-type="supplementary-material"}). The mean age of the participants in the PH cohort was 53.9 (SD = 10.96) years and 56.1 (SD = 10.02) years in the RELAX cohort. The majority of participants in both cohorts were female (PH, 78.2%; RELAX, 71.4%) ([Table 2](#T2){ref-type="table"}).

![CONSORT flow diagram for Self-Directed Biological Transformation Initiative (SBTI) study participants.](fcvm-07-00120-g0004){#F4}

###### 

Comparison of baseline characteristics across the RELAX and PH study groups.

                                            **PH**           **RELAX**
  ----------------------------------------- ---------------- ----------------
  *N*                                       57               30
  Age \[mean (SD)\]                         53.87 (10.96)    56.15 (10.02)
  Gender = female (%)                       43 (78.2)        20 (71.4)
  Height \[mean (SD)\]                      66.34 (3.41)     66.13 (4.19)
  Weight \[mean (SD)\]                      150.09 (31.26)   155.19 (41.45)
  **Hours of MultiSense patch recording**                    
  Session 1 \[mean (SD)\]                   80.18 (37.92)    59.35 (32.24)
  Session 2 \[mean (SD)\]                   39.38 (9.17)     36.97 (29.38)
  Session 3 \[mean (SD)\]                   80.37 (32.11)    72.53 (28.24)

The three primary physiological parameters of heart rate, heart rate variability, and average accelerations showed similar marginal distributions across the three sessions ([Figure 5](#F5){ref-type="fig"}). The average heart rate was 72.5 (SD = 13.6) beats per minute (bpm) with significant differences across gender (female = 73.7 ± 14.0 bpm, male = 68.7 ± 11.7 bpm, *p* \< 0.0001, [Figure 5](#F5){ref-type="fig"}). The mean HRV for the cohort was 37.7 (SD = 24.2) ms with a significant difference between gender (mean female = 38.9, male = 33.8, *p* \< 0.0001).

![Density histograms of heart rate (HR), select features related to heart rate variability (HRV), and overall physical activity stratified by gender.](fcvm-07-00120-g0005){#F5}

Cohort-Level Assessment of HRV and Salivary Cortisol Levels
-----------------------------------------------------------

The cohort level model showed a limited statistically significant impact of wellness center visit on the study participants assessed by evaluating differences in HR- and HRV-related features ([Supplementary Figure 2](#SM1){ref-type="supplementary-material"}). The topmost HRV features associated with the covariates of interest are presented here with the complete results from GEE models available as part of the [Supplementary Table 2](#SM1){ref-type="supplementary-material"}. At the population level, participant\'s age was statistically significantly associated with HRV feature ALF \[β = 0.98 (CI = 0.96--0.98), false discovery rate (FDR) \< 0.001\]. Participants\' BMI was also found to be statistically significantly associated the most with HRV feature PLF \[β = 0.98 (CI = 0.98--1), FDR = 0.005). The high-frequency biosignals were also sensitive to capture the diurnal variations and the impact of physical activity on HR and HRV. For example, the daily variation in heart rate was significantly associated with the time of day \[β~evening\ vs.\ earlymorning~= 29.60 (CI = 13.35--45.85), FDR \< 0.001\]. HRV-related feature LF/HF ratio was also associated jointly with the time of day and physical activity \[β~ACT:night\ vs.\ earlymorning~= 2.69 (CI = 1.7--4.27), FDR \< 0.001\]. A statistically significant interaction between the wellness center visit and time of day was also found. All participants regardless of the subcohort (PH, RELAX) showed a significant difference in HR- or HRV-related features during session 2 (wellness center visit) in the morning and afternoon period compared to session 1 (at home). Specifically, a marginally significant decrease in heart rate was seen during the afternoon for all participants \[β = −4.26 (CI = −7.58---0.94), FDR = 0.03\], and HRV feature ALF showed statistically significant increase during the morning \[β= 1.48 (CI = 1.23--1.82), FDR \< 0.001\] and afternoon \[β= 1.55 (CI = 1.23--1.95), FDR = 0.001\] during the wellness center visit. While a marginally statistically significant difference in one HRV-related feature PLF was observed between PH and RELAX cohort \[β= 0.66 (CI = 0.49--0.89), FDR = 0.04\], the change was not persistent over time (session 3). Additionally, while the salivary cortisol assay was sensitive to capturing the known diurnal variations ([@B41], [@B42]) in cortisol levels, no other significant differences in both PH and RELAX cohorts based on wellness center visits were observed ([Figure 7](#F7){ref-type="fig"}, [Supplementary Table 3](#SM1){ref-type="supplementary-material"}).

Personalized *N*-of-1 Analysis
------------------------------

With a high level inter- and intraperson variability in HRV features, personalized *N*-of-1 models for a subset of individuals (*N* = 22) that contributed data for at least 24 h across all three sessions were evaluated. [Figure 6](#F6){ref-type="fig"} summarizes the HRV variation at an individual level along with deviation from the median HRV of the cohort for each session. Personalized models showed statistically significant differences in at least one of the features related to HRV for 45.5% (*N* = 10) individuals in session 1 vs. 2 (home vs. wellness center visit). However, a significantly larger proportion of the participants 81.8% (*N* = 18) showed a statistically significant difference in session 1 vs. 3 (pre- vs. post-visit home) in at least one of the HRV-related features. [Figure 8](#F8){ref-type="fig"} shows the *p*-values (FDR corrected) obtained from the robust Newey--West regression of the pairwise differences in HRV-related features across the three sessions showing varying response patterns across participants. The results show a highly individualized response to wellness center visits. Across the heterogeneous patterns of response ([Figure 8](#F8){ref-type="fig"}), we observed four broad profiles of participant response: (1) no statistically significant difference in HRV across the three sessions; (2) long-term responder where participant showed a statistically change in HRV during the wellness center visit (session 2) compared to the at-home assessment before wellness center visit (session 1) and persistence of change on participants\' return to home (session 3) after wellness center visit; (3) short-term responder showing an increased HRV in session 2;however, it regressed toward the baseline mean in session 3; and finally, (4) decreased in HRV in session 2 that persists in the session 3 ([Figure 9](#F9){ref-type="fig"}). Significant intraperson variability in cortisol levels in the morning time \[interquartile range (IQR) = 3.1--33\] was seen compared to afternoon and evening (IQR = 1.1--1.8) ([Supplementary Figure 3](#SM1){ref-type="supplementary-material"}). However, no statistical test was used to assess *N*-of-1 differences in cortisol levels due to the limited number of data points per participant ([Supplementary Figure 4](#SM1){ref-type="supplementary-material"}).

![Cortisol levels (nmol/L) across the six different times of the day. Cohort level model shows no statistically significant differences in cortisol levels between RELAX and PH cohort.](fcvm-07-00120-g0006){#F6}

![Boxplots of individual-level mean hourly heart rate variability feature, SDNN (log~10~) across the three study sessions colored by participants\' cohort status. The vertical orange line in each session shows the median value of the cohort for each session.](fcvm-07-00120-g0007){#F7}

![Heatmap of false discovery rate (FDR) corrected *p*-values from personalized models comparing heart rate variability (HRV)-related features across session 1 vs. 2 (home vs. wellness center visit) and session 1 vs. 3 (pre vs. post visit at home). Significantly associated HRV features (FDR \< 0.05) across individuals are shown using magenta color with darker hue showing stronger significance.](fcvm-07-00120-g0008){#F8}

![Four different profiles of individuals selected on the basis of personalized response to wellness center visit. **(A)** No significant difference in standard deviation of interbeat intervals (SDNN) across the three sessions. **(B)** Long-term responder, **(C)** short-term responder, and **(D)** persistent decrease in SDNN.](fcvm-07-00120-g0009){#F9}

Discussion {#s4}
==========

We sought to better understand changes in HRV over time and how it can be influenced, both in the short and longer term, by active participation in week-long wellness or vacation relaxation interventions. Key findings from our study show the potential utility of continual real-world monitoring of HRV to assess individualized response to health and wellness interventions including inter- and intraperson variability over time. Our findings provide further evidence of the value of utilizing personalized and longitudinal physiological monitoring approaches for assessing individualized health and wellness ("precision health") ([@B43]).

The cohort level models showed the efficacy of HR- and HRV-related biosignals collected in real-world settings to be associated with known demographic and physiological characteristics such as age ([@B44]), BMI ([@B45]), and physical activity ([@B46]). While we did not find a significant and persistent difference in HRV response among those participating in the PH program vs. the regular vacation (RELAX), both groups showed a significant positive increase in HRV while being at a resort location. This confirms that a relaxing environment does, at least on a population level, lead to an overall general increase in parasympathetic activity due to, presumably, a decrease in stress. As has been previously described ([@B41], [@B42]), significant diurnal variations in HRV were also observed at the individual level that should be taken into consideration while analyzing longitudinal physiological data. This variation could also be associated with long-term health, manifested by nocturnal drops in blood pressure and pulse ([@B47]).

Through continuous monitoring, we identified individuals with varying degrees of HRV responses in the three different sessions. Some individuals (exemplified by participant S157) were found to have a significant increase in HRV during session 2, which was maintained through follow-up in session 3, supporting a relaxation response that was sustained ([Figure 9B](#F9){ref-type="fig"}). Others, such as participant S125, were found to have an increase in HRV during session 2, but by session 3, both had returned to session 1 levels ([Figure 9C](#F9){ref-type="fig"}). Finally, the two other cases were consistent with no relaxation or with both no significant HRV differences across the sessions (S109, [Figure 9A](#F9){ref-type="fig"}) or with a significant decrease in HRV (S103, [Figure 9D](#F9){ref-type="fig"}) in sessions 2 and 3 compared to session 1.

HRV has been suggested to be of value as an objective measure of an individual\'s level of stress or calmness, as it measures fluctuations in autonomic nervous system input to the heart and the changing balance between parasympathetic and sympathetic systems influences. With the growing availability of sensor technologies designed for personal use that are able to continuously track heart rate and HRV, this can provide people with valuable insights into their stress level, and potentially more importantly, an understanding of what activities impact that level, both positively or negatively. While prior studies have confirmed that HRV changes track well with acute emotional stress, such as when skydiving, its value in measuring long-term changes in calmness has been more difficult to study ([@B48]).

A wide range of personal digital health technologies ([@B12]) has recently made it much easier for interested individuals to measure their heart rate, either by using pulse rate measured via photoplethysmography (PPG), common to many smartwatches or other wearable devices, or by ECG. While both methods appear to be equally accurate for measuring heart rate, especially at rest, the very subtle, millisecond differences in measurements of beat-to-beat variation in heart rate are still more accurately assessed using an ECG ([@B49]). For an individual to track their own ECG, current devices available to consumers only allow for very short (usually 30 s) sampling of HR and HRV. Our results suggest that such instantaneous snapshots of HRV may not adequately capture important situational changes unless tracked at high frequency. In fact, much of the existing data on HRV and clinical outcomes are based on just 24 h of ECG recording. Until PPG sensors can be further refined, ECG-based wearables, especially multiday wear ECG patches as used in the current study, are likely to be most valuable in tracking daily and day-to-day fluctuations in HRV ([@B50]). Additionally, while salivary cortisol is frequently used as a biomarker of stress ([@B51], [@B52]), in the present sample, we did not find any significant changes in cortisol levels at the cohort level besides the known diurnal variations. This may further suggest the utility of high-frequency sensor-based objective assessment of physiological changes such as HRV over infrequent biological assays that may not be able to capture the dynamic response. Individualized differences in cortisol levels were not assessed due to limited data (one measurement per time of day) across sessions.

Most of what is currently known about HRV as a measure of risk in cardiovascular disease is based on population-level cutoffs of risk ([@B23]). Our findings suggest that with such high heterogeneity in HRV levels among individuals, a more meaningful measure of changes in autonomic activity would be based on deviations from individual-level baselines over time. In addition, external factors such as medications ([@B53]) and mood disorders ([@B54]) can impact an individual\'s HRV, making it even more important to track individualized responses. Heart rate recovery after exercise is another measure of autonomic nervous system input to the heart that is determined by recording the velocity of decrease in heart rate following exercise and has also been found to be associated with cardiovascular outcomes ([@B55]). Although it is highly personalized based on an individual\'s exercise capacity, the expected decrease in heart rate at 1 or 2 min after exertion is population based. In our study, HRV was correlated with activity during monitoring, but that might just have been a surrogate for individuals\' levels of activity, and therefore cardiorespiratory fitness and vagal activity prior to participation. Novel personal wearable sensors ([@B12])---including watches, rings, clothing, earphones, and more---that allow a person\'s unique changes in HR and HRV to be continuously monitored and benchmarked to themselves rather than a population norm may have great value in improving wellness and preventing both mental and cardiovascular disease. The findings support the viability of the continuous tracking of HRV to objectively measure an individual\'s response to potentially stressful or relaxing stimuli. Approaches to wellness, whether structured or unstructured, can support the restoration of HRV.

The present study also surfaces challenges in the use of wearable technology for longitudinal monitoring. Recent research has shown that participant retention ([@B56]) and compliance ([@B57]), i.e., the amount of time the wearable sensor patch is worn continuously, remains a challenge. Of the 112 enrolled participants, only 22 (19.6%) wore the patch for at least 24 h across all three sessions. The resulting data sparsity affected cohort and individual-level analyses, restricting the use of more generalized methods such as mixed effect models. However, despite the present data collection challenges, the use of wearable technology was shown to have a promising prospect for fully remote prospective intervention trials. The ability to objectively assess individualized physiological responses to interventions in a real-world setting at scale and at a fraction of the cost could help advance our ability to assess potential beneficial effects of a multiple of different types of wellness intervention programs.

Conclusion {#s5}
==========

Simple, wearable sensors enable the ability to continuously monitor HRV during routine daily activities. Personalized HRV analysis at an individual level showed distinct HRV trajectories, further supporting the utility of using continuous real-world tracking of HRV at an individual level to objectively measure responses to potentially stressful or relaxing settings. This holds promise for identifying personalized stress and calm. However, there remain substantial challenges to fully understanding how to best measure it to extract actionable data to benefit the individual.
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